NCT03331458

Brief Summary

Recent research has indicated that physical activities incorporating moderate-intensity exercise can be safely performed during treatment and substantially reduces treatment-related side effects, such as fatigue, sleep disturbances, cognitive impairment, and nausea. However, little is known about physical activity levels prior to treatment and whether providing an exercise intervention pre-treatment may improve functional capacity during treatment. The purpose of this study is to

  1. 1.Measure physical activity levels and functional capacity in men newly diagnosed with prostate cancer prior to treatment and
  2. 2.Explore whether a 2-week physical activity intervention is feasible during the pre-treatment timeframe:
  3. 3.Examine intervention safety and tolerance by self-report
  4. 4.Examine changes in functional capacity by 6-minute walk test
  5. 5.Examine changes in symptom experience by self-report

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
13

participants targeted

Target at below P25 for not_applicable prostate-cancer

Timeline
Completed

Started Apr 2018

Shorter than P25 for not_applicable prostate-cancer

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 1, 2017

Completed
5 days until next milestone

First Posted

Study publicly available on registry

November 6, 2017

Completed
5 months until next milestone

Study Start

First participant enrolled

April 17, 2018

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 21, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 21, 2019

Completed
Last Updated

August 26, 2019

Status Verified

August 1, 2019

Enrollment Period

11 months

First QC Date

November 1, 2017

Last Update Submit

August 22, 2019

Conditions

Keywords

physical activity

Outcome Measures

Primary Outcomes (9)

  • Change in 6 minute walk test

    Distance walked in 6 minutes

    baseline, 2 weeks post intervention

  • Change in balance test

    Ability to balance

    baseline, 2 weeks post intervention

  • Change in time up to go test

    Time to get up from chair, walk 30 meters and return to sit in chair

    baseline, 2 weeks post intervention

  • Change in Godin Leisure Time Score

    physical activity score

    baseline, 2 weeks post intervention

  • Change in rate of perceived exertion

    physical exertion score

    baseline, 2 weeks post intervention

  • Change in metabolic equivalent

    metabolic activity score

    baseline, 2 weeks post intervention

  • Change in distress score

    distress score

    baseline, 2 weeks post intervention

  • Change in self-efficacy score

    self-efficacy score

    baseline, 2 weeks post intervention

  • Change in symptom inventory score

    description of symptoms

    baseline, 2 weeks post intervention

Study Arms (1)

subjects with prostate cancer

EXPERIMENTAL
Behavioral: exrecise intervention

Interventions

Subjects will undergo pre-intervention measures, complete a daily physical activity diary, and post-intervention measures

subjects with prostate cancer

Eligibility Criteria

Age18 Years+
Sexmale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Newly diagnosed with prostate cancer
  • will not start treatment for at least 2 weeks
  • able to read and understand English
  • capable of giving informed consent
  • at least 18 years old

You may not qualify if:

  • patients who are incompetent for interview (documented diagnosis of active psychosis or dementia)
  • unable to provide informed consent as assessed by the interviewer
  • too sick to participate, as judged by a member of the research team or the exercise physiologist
  • have been treated for another cancer

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Duke Raleigh Cancer Center

Raleigh, North Carolina, 27606, United States

Location

MeSH Terms

Conditions

Prostatic NeoplasmsMotor Activity

Condition Hierarchy (Ancestors)

Genital Neoplasms, MaleUrogenital NeoplasmsNeoplasms by SiteNeoplasmsGenital Diseases, MaleGenital DiseasesUrogenital DiseasesProstatic DiseasesMale Urogenital DiseasesBehavior

Study Officials

  • Deborah Allen

    Duke University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 1, 2017

First Posted

November 6, 2017

Study Start

April 17, 2018

Primary Completion

March 21, 2019

Study Completion

March 21, 2019

Last Updated

August 26, 2019

Record last verified: 2019-08

Data Sharing

IPD Sharing
Will not share

No plan to share feasibility study data

Locations